EVolution Therapeutics

EVolution Therapeutics is a preclinical-stage biotechnology company developing mRNA nanoparticle and hydrogel-based therapeutics to resolve chronic inflammation and support tissue repair.

Spun out of Aston University, its platform delivers mRNA encoding pro-resolving proteins directly to sites of disease.

The lead programme targets non-healing wounds, with further potential across inflammatory skin, pulmonary, cardiovascular and fibrotic disease, addressing patients affected by chronic, unresolved inflammation.